Myocardial regeneration with stem cells: Pharmacological possibilities for efficacy enhancement

Pharmacological Research

Volumn 53, Issue 4, 2006, Pages 331-340

  Wang, Qing Dong ^a   Sjöquist, Per Ove ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Heart failure; Ischaemia; Myocardium; Pharmacology; Regeneration; Stem cell

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; AZACITIDINE; CARDIOGENOL A; CARDIOGENOL B; CARDIOGENOL C; CARDIOGENOL D; DEXAMETHASONE; DIMETHYL SULFOXIDE; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYTOCIN; PROTEIN INHIBITOR; PYRIMIDINE DERIVATIVE; RETINOIC ACID; SCATTER FACTOR; SOMATOMEDIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

CARDIOMYOPATHY; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; CLINICAL TRIAL; EMBRYONIC STEM CELL; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE REGENERATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; MOLECULE; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL TRANSPLANTATION; SURVIVAL; TARGET ORGAN; TISSUE REPAIR; TREATMENT OUTCOME;

ANIMALS; CELL TRANSPLANTATION; HEART DISEASES; HUMANS; MYOCARDIUM; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 33646368685     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.01.009     Document Type: Review

References (87)

1. Jessup M., and Brozena S. Heart failure. N Engl J Med 348 (2003) 2007-2018
2. Murry C.E., Wiseman R.W., Schwartz S.M., and Hauschka S.D. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest 98 (1996) 2512-2523
3. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
4. Assmus B., Schachinger V., Teupe C., Britten M., Lehmann R., Dobert N., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
5. Menasché P., Hagége A.A., Vilquin J.T., Desnos M., Abergel E., Pouzet B., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41 (2003) 1078-1083
6. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Mesquita C.T., et al. Transendocardial autologous bone marrow cell transplantation for severe chronic ischemic heart failure. Circulation 107 (2003) 2294-2302
7. Chen S.L., Fang W.W., Ye F., Liu Y.H., Qian J., Shan S.J., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94 (2004) 92-95
8. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
9. Kang H.J., Kim H.S., Zhang S.Y., Park K.W., Cho H.J., Koo B.K., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363 (2004) 751-756
10. Schächinger V., Assmus B., Britten M., Honold J., Lehmann R., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 44 (2004) 1690-1699
11. Siminiak T., Fiszer D., Jerzykowska O., Grygielska B., Rozwadowska N., Kalmucki P., et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial. Eur Heart J 26 (2005) 1188-1195
12. Kuethe F., Richartz B.M., Sayer H.G., Kasper C., Werner G.S., Hoffken K., et al. Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int J Cardiol 97 (2004) 123-127
13. Schächinger V., Erbs S., Elsässer A., Haberbosch W., Hambrecht R., Hölschermann H., et al. Intracoronary infusion of bone marrow-derived progenitor cells in acute myocardial infarction: a randomized, double-blind, placebo-controlled multicenter trial (REPAIR-AMI) (abstract). Circulation 112 (2005) 3362
14. Menasché P. Skeletal myoblast for cell therapy. Coron Artery Dis 16 (2005) 105-110
15. Dimmeler S., Zeiher A.M., and Schneider M.D. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115 (2005) 572-583
16. Wollert K.C., and Drexler H. Clinical applications of stem cells for the heart. Circ Res 96 (2005) 151-163
17. Menasché P., Hagége A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., et al. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
18. Herreros J., Prosper F., Perez A., Gavira J.J., Garcia-Velloso M.J., Barba J., et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J 24 (2003) 2012-2020
19. Smits P.C., van Geuns R.J., Poldermans D., Bountioukos M., Onderwater E.E., Lee C.H., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure. J Am Coll Cardiol 42 (2003) 2063-2069
20. Siminiak T., Kalawski P., Fiszer D., Jerzykowska O., Rzezniczak J., Rozwadowska N., et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 148 (2004) 531-537
21. Chachques J.C., Herreros J., Trainini J., Juffe A., Rendal E., Prosper F., et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 95 Suppl I (2004) S29-S33
22. Pagani F., DerSimonian H., Zawadzka A., Wetzel K., Edge A.S., Jacoby D.B., et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 41 (2003) 879-888
23. Hagége A.A., Carrion C., Menasché P., Vilquin J.T., Duboc D., Marolleau J.P., et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 361 (2003) 491-492
24. Pera M.F., Reubinoff B., and Trounson A. Human embryonic stem cells. J Cell Sci 113 (2000) 5-10
25. Smith A.G., Heath J.K., Donaldson D.D., Wong G.G., Moreau J., Stahl M., et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336 (1988) 688-690
26. Odorico J.S., Kaufman D.S., and Thomson J.A. Multilinage differentiation from human embryonic stem cell lines. Stem Cells 19 (2001) 193-204
27. Kumar D., Kamp T.J., and LeWinter M.M. Embryonic stem cells: differentiation into cardiomyocytes and potential for heart repair and regeneration. Coron Artery Dis 16 (2005) 111-116
28. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108 (2001) 407-414
29. Min J.Y., Yang Y.Y., Converso K.L., Liu L., Huang Q., Morgan J.P., et al. Transplantation of embryonic stem cells improves cardiac function in post-infarcted rats. J Appl Physiol 92 (2002) 288-296
30. Min J.Y., Yang Y., Sullivan M.F., Ke Q., Converso K.L., Chen Y., et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 125 (2003) 361-369
31. Hodgson D.M., Behfar A., Zingman L.V., Kane G.C., Perez-Terzic C., Alekseev A.E., et al. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol 287 (2004) H471-H479
32. Ménard C., Hagége A.A., Agbulut O., Barro M., Morichetti M.C., Brasselet C., et al. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366 (2005) 1005-1012
33. Laflamme M.A., Gold J., Xu C., Hassanipour M., Rosler E., Police S., et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 167 (2005) 663-671
34. Cowan C.A., Klimanskaya I., McMahon J., Atienza J., Witmyer J., Zucker J.P., et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350 (2004) 1353-1356
35. Yoon Y.S., Wecker A., Heyd L., Park J.S., Tkebuchava T., Kusano K., et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115 (2005) 326-338
36. Bittner R.E., Schofer C., Weipoltshammer K., Ivanova S., Streubel B., Hauser E., et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol 199 (1999) 391-396
37. Haider H.K., and Ashraf M. Bone marrow cell transplantation in clinical perspective. J Mol Cell Cardiol 38 (2005) 225-235
38. Jackson K.A., Majka S.M., Wang H., Pocius J., Hartley C.J., Majesky M.W., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107 (2001) 1395-1402
39. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
40. Bel A., Messas E., Agbulut O., Richard P., Samuel J.L., Bruneval P., et al. Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation 108 Suppl II (2003) II247-II252
41. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
42. Balsam L.B., Wagers A.J., Christensen J.L., Kofidis T., Weissman I.L., and Robbins R.C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
43. Majumdar M.K., Keane-Moore M., Buyaner D., Hardy W.B., Moorman M.A., and McIntosh K.R. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10 (2003) 228-241
44. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., and Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
45. Dai W., Hale S.L., Martin B.J., Kuang J.Q., Dow J.S., Wold L.E., et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112 (2005) 214-223
46. Jaquet K., Krause K.T., Denschel J., Faessler P., Nauerz M., Geidel S., et al. Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism?. Stem Cells Dev 14 (2005) 299-309
47. Urbich C., and Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 14 (2004) 318-322
48. Badorff C., Brandes R.P., Popp R., Rupp S., Urbich C., Aicher A., et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107 (2003) 1024-1032
49. Kajstura J., Leri A., Finato N., Di Loreto C., Beltrami C.A., and Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 95 (1998) 8801-8805
50. Beltrami A.P., Urbanek K., Kajstura J., Yan S.M., Finato N., Bussani R., et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344 (2001) 1750-1757
51. Quaini F., Urbanek K., Beltrami A.P., Finato N., Beltrami C.A., Nadal-Ginard B., et al. Chimerism of the transplanted heart. New Engl J Med 346 (2002) 5-15
52. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-766
53. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100 (2003) 12313-12318
54. Matsuura K., Nagai T., Nishigaki N., Oyama T., Nishi J., Wada H., et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 279 (2004) 11384-11391
55. Martin C.M., Meeson A.P., Robertson S.M., Hawke T.J., Richardson J.A., Bates S., et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Bio 265 (2004) 262-275
56. Laugwitz K.L., Moretti A., Lam J., Gruber P., Chen Y., Woodard S., et al. Postnatal isl1 + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433 (2005) 1647-1653
57. Dawn B., Stein A.B., Urbanek K., Rota M., Whang B., Rastaldo R., et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci USA 102 (2005) 3766-3771
58. Cai C.L., Liang X., Shi Y., Chu P.H., Pfaff S.L., Chen J., et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5 (2003) 877-889
59. Leri A., Kajstura J., and Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 85 (2005) 1373-1416
60. Urbanek K., Torella D., Sheikh F., De Angelis A., Nurzynska D., Silvestri F., et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA 102 (2005) 8692-8697
61. Messina E., De Angelis L., Frati G., Morrone S., Chimenti S., Fiordaliso F., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95 (2004) 911-921
62. Yoon Y.S., Lee N., and Scadova H. Myocardial regeneration with bone-marrow-derived stem cells. Biol Cell 97 (2005) 253-263
63. Müller P., Beltrami A.P., Cesselli D., Pfeiffer P., Kazakov A., and Böhm M. Myocardial regeneration by endogenous adult progenitor cells. J Mol Cell Cardiol 39 (2005) 377-387
64. Singla D.K., and Sobel B.E. Enhancement by growth factors of cardiac myocyte differentiation from embryonic stem cells: a promising foundation for cardiac regeneration. Biochem Biophys Res Commun 335 (2005) 637-642
65. Takahashi T., Lord B., Schulze P.C., Fryer R.M., Sarang S.S., Gullans S.R., et al. Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107 (2003) 1912-1916
66. Wu X., Ding S., Ding Q., Gray N.S., and Schultz P.G. Small molecules that induce cardiomyogenesis in embryoic stem cells. J Am Chem Soc 126 (2004) 1590-1591
67. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103 (1999) 697-705
68. Askari A.T., Unzek S., Popovic Z.B., Goldman C.K., Forudi F., Kiedrowski M., et al. Effect of stromal-cell-derived factor-1 on stem cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362 (2003) 697-703
69. Lu L., Zhang J.Q., Ramires F.J., and Sun Y. Molecular and cellular events at the site of myocardial infarction: from the perspective of rebuilding myocardial tissue. Biochem Biophys Res Commun 320 (2004) 907-913
70. Abbott J.D., Huang Y., Liu D., Hickey R., Krause D.S., and Giordano F.J. Stromal cell-derived factor-1a plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110 (2004) 3300-3305
71. Ma L., Ge J., Zhang S., Sun A., Shen J., Chen L., et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 100 (2005) 217-223
72. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10 (2004) 858-864
73. Staller P., Sulitkova J., Lisztwan J., Moch H., Oakeley E.J., and Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425 (2003) 307-311
74. Siddiq A., Ayoub I.A., Chavez J.C., Aminova L., Shah S., LaManna J.C., et al. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition: a target for neuroprotection in the central nervous system. J Biol Chem 280 (2005) 41732-41743
75. Heeschen C., Lehmann R., Honold J., Assmus B., Aicher A., Walter D.H., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109 (2004) 1615-1622
76. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
77. Schmidt-Lucke C., Rössig L., Fichtlscherer S., Vasa M., Britten M., Kämper U., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005) 2981-2987
78. Edelberg J.M., Tang L., Hattori K., Lyden D., and Rafii S. Young adult bone marrow-derived endothelial progenitor cells restore aging-impaired cardiac angiogenic function. Circ Res 90 (2002) e89-e93
79. Rupp S., Badorff C., Koyanagi M., Urbich C., Fichtlscherer S., Aicher A., et al. Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Res Cardiol 99 (2004) 61-68
80. Spyridopoulos I., Haendeler J., Urbich C., Brummendorf T.H., Oh H., Schneider M.D., et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 110 (2004) 3136-3142
81. Seeger F.H., Haendeler J., Walter D.H., Rochwalsky U., Reinhold J., Urbich C., et al. p38 Mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111 (2005) 1184-1191
82. Zhang M., Methot D., Poppa V., Fujio Y., Walsh K., and Murry C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33 (2001) 907-921
83. Azarnoush K., Maurel A., Sebbah L., Carrion C., Bissery A., Mandet C., et al. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1α. J Thorac Cardiovasc Surg 130 (2005) 173-179
84. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 (2003) 1195-1201
85. Oh I.S., So S.S., Jahng K.Y., and Kim H.G. Hepatocyte growth factor upregulates thymosin β4 in human umbilical vein endothelial cells. Biochem Biophys Res Commun 296 (2002) 401-405
86. Urbanek K., Rota M., Cascapera S., Bearzi C., Nascimbene A., De Angelis A., et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res 97 (2005) 663-673
87. Linke A., Müller P., Nurzynska D., Casarsa C., Torella D., Nascimbene A., et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 102 (2005) 8966-8971